22:42 27.03.2008, Elevated levels of interleukin-6 and D-dimer are associated with an increased risk of death in patients with HIV(Presented at CROI)
Elevated levels of interleukin-6 and D-dimer are associated with an increased risk of death in patients with HIV(Presented at CROI)
21:57 27.03.2008, Age and Sex-specific Death Rates In ART-naive Patients with CD4 counts above 350 cells compared with the General population(Presented at CROI)
Age and Sex-specific Death Rates In ART-naive Patients with CD4 counts above 350 cells compared with the General population(Presented at CROI).
21:19 22.03.2008, HIV-1 rebound during ART interruption is associated with a preferential depletion of CD4+PO T Cells from the Gastrointestinal Tract
HIV-1 rebound during ART interruption is associated with a preferential depletion of CD4+PO T Cells from the Gastrointestinal Tract
20:58 22.03.2008, Evidence for Persistent Viral Replication in lymph nodes and Gut Associated Lymphoid tissue (GALT) of ARV treated patients
Evidence for Persistent Viral Replication in lymph nodes and Gut Associated Lymphoid tissue (GALT) of ARV treated patients
20:17 22.03.2008, Bacterial DNA is measurable in Plasma of HIV infected patients and are diminished by Treatment with HAART
Bacterial DNA is measurable in Plasma of HIV infected patients and are diminished by Treatment with HAART
21:36 21.03.2008, New insights into retrovirus host cell interactions-Paul Bieniasz, Aaron Diamond Research Center, Rockefeller Center New York, Presented at CROI
New insights into retrovirus host cell interactions(Paul Bieniasz, Aaron Diamond Research Center, Rockefeller Center New York, Presented at CROI)
21:06 21.03.2008, Pneumonia Vaccine works well in people with HIV(NAM-March12,2008)
Pneumonia Vaccine works well in people with HIV(NAM-March 12,2008)
20:35 21.03.2008, Ways of boosting the CD4 cell count-IL7 and Growth Hormone (NAM-March12, 2008)
Ways of boosting the CD4 cell count-IL7 and Growth Hormone (NAM-March12, 2008)
11:43 19.03.2008, Epidemiology of HIV, including response to ART in Older Populations
Epidemiology of HIV, including response to ART in Older Populations
10:57 19.03.2008, New Drug in development for HIV Bevirimat
New Drug in development for HIV Bevirimat
14:33 09.03.2008, Efficacy and Safety of once-daily Atazanavir/Ritonavir compared to twice daily Lopinavir/Ritonavir.
Efficacy and Safety of once-daily Atazanavir/Ritonavir compared to twice daily Lopinavir/Ritonavir
13:57 09.03.2008, Re-initiation of ART in the CD4 guided ART interruption study lowers risk of opportunistic infection or death.
Re-initiation of ART in the CD4 guided ART interruption study lowers risk of opportunistic infection or death
12:55 09.03.2008, Comprehensive pre-clinical assessment of Microbicide safety using in Vitro and Murine Models
Comprehensive pre-clinical assessment of Microbicide safety using in Vitro and Murine Models
22:48 07.03.2008, RESEARCHERS AT HARVARD MEDICAL SCHOOL IDENTIFY A NEW WAY TO ATTACK HIV
RESEARCHERS AT HARVARD MEDICAL SCHOOL IDENTIFY A NEW WAY TO ATTACK HIV